| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/30/2006 | US20060067972 Devices for renal-based heart failure treatment |
| 03/30/2006 | US20060067966 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 03/30/2006 | US20060067959 Compositions and methods for treatment of solar damage |
| 03/30/2006 | US20060067954 Lipid stabilized formulations |
| 03/30/2006 | US20060067953 Oral pharmaceutical formulations and methods for producing and using same |
| 03/30/2006 | US20060067952 Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| 03/30/2006 | US20060067947 Immunotherapeutic for cancer |
| 03/30/2006 | US20060067943 Stabilization of alum-adjuvanted immunologically active agents |
| 03/30/2006 | US20060067938 Methods for the treatment of osteoarthritis and compositions thereof |
| 03/30/2006 | US20060067937 Methods of diagnosing and treating complications of pregnancy |
| 03/30/2006 | US20060067934 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067928 Contacting a linear polysaccharide with a disaccharide repeat unit of a uronic acid [ alpha -L-iduronic acid (I) or beta -D-glucuronic acid] linked 1, 4 to alpha -D-hexosamine with a modified heparinase III in vitro |
| 03/30/2006 | US20060067927 Methods and compositions related to the modulation of intercellular junctions |
| 03/30/2006 | US20060067925 Method and composition for inhibiting reperfusion injury in the brain |
| 03/30/2006 | US20060067919 Colon cancer metastasis inhibitor |
| 03/30/2006 | US20060067910 Polyethylene glycol-polyglutamic acid block copolymer conjugates with e.g. 7-ethyl-10-hydroxycamptothecin or topotecan for sustained release; water solubility, anticancer agents |
| 03/30/2006 | US20060067909 Peptide-modified polyurethane compositions and associated methods |
| 03/30/2006 | US20060067908 Methacrylate copolymers for medical devices |
| 03/30/2006 | US20060067898 10 weight % terbinafine hydrochloride, 0.5 % dodecyl 2-(N,N-dimethylamino)propionate hydrochloride and 0.75 % benzyl alcohol to enhance penetration; 0.5 % polyvinylpyrrolidone, and the remainder ethanol; duel delivery through nail and skin increases topical bioavailability; onychomycosis |
| 03/30/2006 | US20060067892 Topical nanoparticulate spironolactone formulation |
| 03/30/2006 | US20060067889 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents |
| 03/30/2006 | DE202006000591U1 Composition useful for providing nutrients to healthy joints, comprises glucosamine, chondroitin, copper salt, selenium salt in rapid-release form and vitamins C, E, B6 and B12, folic acid, zinc salt, manganese salt in delayed-release form |
| 03/30/2006 | DE112004000762T5 Verwendung von Triglyceridölen, die gamma-Linolensäurereste und Linolsäurereste enthalten, zur Behandlung von neurodegenerativer Krankheit The use of triglyceride oils, the gamma-linolenic acid and linoleic acid residues contained, for the treatment of neurodegenerative disease |
| 03/30/2006 | DE102005014240A1 Antibakterielle Amid-Makrozyklen IV Antibacterial amide macrocycles IV |
| 03/30/2006 | DE102004047840A1 Neue substituierte Thiophencarbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel New substituted thiophenecarboxamides, their preparation and their use as medicaments |
| 03/30/2006 | DE102004047517A1 Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid Novel crystal form of (3-cyano-1H-indol-7-yl) - [4- (4-fluorophenethyl) piperazin-1-yl] -methanone, hydrochloride |
| 03/30/2006 | DE102004046623A1 Neue Pyrimidin-Derivate und ihre Verwendung New pyrimidine derivatives and their use |
| 03/30/2006 | DE102004046583A1 New D-xylopyranosyl-phenyl-substituted cycle compounds useful for treating e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis |
| 03/30/2006 | DE102004046530A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| 03/30/2006 | DE102004046492A1 Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament Substituted 4-Phenyltetrahydroisochinoline, processes for their preparation, their use as a medicament, and medicament containing them |
| 03/30/2006 | DE102004046236A1 Arzneimittelzubereitung The pharmaceutical preparation |
| 03/30/2006 | DE102004046235A1 Arzneimittelzubereitung The pharmaceutical preparation |
| 03/30/2006 | DE102004046024A1 Antibiotikum und Verfahren zur Herstellung Antibiotic and methods for preparing |
| 03/30/2006 | DE102004044555A1 New modification of 2-indenylbutyric acid derivative, useful for treating e.g. diabetes and obesity, thermodynamically stable at room temperature |
| 03/30/2006 | DE102004043944A1 Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 8- (3-amino-piperidin-1-yl) -xanthines -7- (but-2-ynyl), their preparation and their use as medicaments |
| 03/30/2006 | DE102004043938A1 Pentafluorosulfanylphenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 03/30/2006 | CA2623471A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| 03/30/2006 | CA2619256A1 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 03/30/2006 | CA2597410A1 Substituted morphinans and methods of their use |
| 03/30/2006 | CA2593202A1 Quaternary alkaloid derivatives of chelidonium majus l |
| 03/30/2006 | CA2588280A1 Oxazole derivatives as her tyrosine kinase inhibitors |
| 03/30/2006 | CA2582766A1 Isomigrastatin analogs in the treatment of cancer |
| 03/30/2006 | CA2582512A1 Compounds, compositions containing them, preparations thereof and uses thereof ii |
| 03/30/2006 | CA2582507A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 03/30/2006 | CA2582492A1 Novel pyrimidine derivatives and their use |
| 03/30/2006 | CA2581673A1 C-aryl glucoside sglt2 inhibitors and method |
| 03/30/2006 | CA2581657A1 Thrombopoietin receptor agonists |
| 03/30/2006 | CA2581623A1 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | CA2581492A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 03/30/2006 | CA2581485A1 Methods and compositions for treating hyperglycemic, hyperlipidemic, or hyperinsulinemic disorders |
| 03/30/2006 | CA2581462A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/30/2006 | CA2581454A1 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | CA2581450A1 Bioreductively-activated prodrugs |
| 03/30/2006 | CA2581388A1 An antioxidant composition and a cosmetic and pharmaceutical compositioncomprising said antioxidant composition |
| 03/30/2006 | CA2581379A1 Calcium trifluoroacetate for the treatment of plasma cell neoplasias |
| 03/30/2006 | CA2581337A1 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
| 03/30/2006 | CA2581336A1 Methods of diagnosing and treating complications of pregnancy |
| 03/30/2006 | CA2581335A1 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 03/30/2006 | CA2581330A1 Methods and compositions relating to mannuronic acid specific binding peptides |
| 03/30/2006 | CA2581316A1 Substituted chroman derivatives, medicaments and use in therapy |
| 03/30/2006 | CA2581287A1 Sustained local anesthetic composition containing bupivacaine and saib |
| 03/30/2006 | CA2581200A1 Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor |
| 03/30/2006 | CA2581180A1 Chemical compounds |
| 03/30/2006 | CA2581175A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 03/30/2006 | CA2581172A1 Carbonyl compound-containing drug and the use thereof |
| 03/30/2006 | CA2581159A1 Treatment of androgen - deprivation induced osteoporosis |
| 03/30/2006 | CA2581150A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors |
| 03/30/2006 | CA2581143A1 Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof |
| 03/30/2006 | CA2581133A1 Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin |
| 03/30/2006 | CA2581132A1 Purine 5'-carboxamide derivatives and their use as adenosine receptor agonists |
| 03/30/2006 | CA2581128A1 Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain |
| 03/30/2006 | CA2581105A1 2-acylaminothiazole derivatives |
| 03/30/2006 | CA2581095A1 Antibiotic and method for production thereof |
| 03/30/2006 | CA2581083A1 Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain |
| 03/30/2006 | CA2581081A1 Lyophilisate containing n-diaminomethylene-2-methyl-4,5-di-(methylsulfonyl)-benzamide |
| 03/30/2006 | CA2581072A1 Compounds for the treatment of dyslipidemia and other lipid disorders |
| 03/30/2006 | CA2581023A1 N-methyl hydroxyethylamine useful in treating cns conditions |
| 03/30/2006 | CA2580924A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them |
| 03/30/2006 | CA2580860A1 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 03/30/2006 | CA2580856A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | CA2580855A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | CA2580852A1 Compounds for inflammation and immune-related uses |
| 03/30/2006 | CA2580845A1 Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 03/30/2006 | CA2580844A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 03/30/2006 | CA2580799A1 Method of treatment for or protection against lymphedema |
| 03/30/2006 | CA2580787A1 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| 03/30/2006 | CA2580781A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 03/30/2006 | CA2580777A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 03/30/2006 | CA2580775A1 N-ethyl hydroxyethylamine useful in treating cns conditions |
| 03/30/2006 | CA2580767A1 Compounds, compositions and methods of inhibiting alpha-synuclein toxicity |
| 03/30/2006 | CA2580759A1 Method and composition for treating patients undergoing kidney dialysis |
| 03/30/2006 | CA2580757A1 Orally administered agent for preventing or improving dry state of skin |
| 03/30/2006 | CA2580749A1 Quinolone analogs |
| 03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
| 03/30/2006 | CA2580722A1 Sustained release pharmaceutical composition |
| 03/30/2006 | CA2580640A1 Methods of treating epileptogensis and epilepsy |
| 03/30/2006 | CA2580639A1 Stable dosing form of phenylalanine derivatives |
| 03/30/2006 | CA2580619A1 Use of memantine (namenda) to treat autism, compulsivity, and impulsivity |
| 03/30/2006 | CA2580610A1 Diaminotriazole compounds useful as protein kinase inhibitors |